Product Images Pemetrexed

This appears to be a graph for "Survival Probability" with "Survival Time (months)" on the x-axis and "3 s H 2 1 w2 oz 0 " on the y-axis. The values on the x-axis are 862, 737, 598, 458, 341, 285, 146, 88, 45, 10, and 0 for both lines plotted. However, the values on the y-axis are not interpretable and appear to be incorrectly recognized characters from the . Therefore, a useful description is not available.*

The text appears to be a list of medical product names and patient IDs along with some numerical values such as survival time measured in months. It is unclear what purpose or context this information serves without additional information.*

This appears to be a section of a graph or chart displaying survival probability and survival time in months. It is not possible to provide further context or information without seeing the full image or data.*

This is a chart showing the survival probability of patients treated with Pometocea and a placebo. The patients at risk are also listed. The chart tracks survival time in months. The text is partially readable, but some characters are not recognizable.*

Patients at Risk who received Pemeterea 116 had a higher exposure than those who received Placsbo 66. Further information about the patients and the study is not available.*

This data appears to be from a clinical trial, displaying the survival probability of patients receiving either Pematrexed or a placebo. The number of patients at risk for each treatment is also provided. However, without more context or information, it is difficult to interpret the data fully.*

This is a pharmaceutical label providing information on Pemetrexed for intravenous use only. It includes a 2D code with encoded data, GTIN, S/N, EXP, and LOT numbers. There are also variable data which shall print online with -B font, with a non-varnish area of 40mm x 35mm. The label contains the drug name, dosage, cautionary statement, instructions for reconstitution, administration and storage conditions, and the manufacturer's information. The label also includes a code for inventory purposes, the volume of medication, the manufacturing date, and the recommended dosage.*

This is a label for Pemetrexed Pemelrexed, a medication for injection, containing 500 mg pemetrexed disodium equivalent. The label includes important information about the drug such as storage temperature, dosage and administration, serial number, and manufacturing information. It also features a 2D code encoded with human-readable data. The dimensions of the label are 55mm x 45mm, and there is a non-varnish area for batch and variable data.*

Pemetrexed is an intravenous cytotoxic agent provided in a single-dose vial of 500 mg. It contains pemetrexed disodium, along with mannitol, in a hydrochloric acid or sodium hydroxide solution, which may be added to adjust pH levels. It should be stored at controlled room temperature and only administered intravenously. The accompanying literature will provide instructions on storing reconstituted and infusion solutions. Manufactured by Gland Pharma Limited in India, it is available from BluePoint Laboratories.*